Trial intelligence / Profile preview

Intravenous lidocaine to reduce alfentanil use during colonoscopy with procedural sedation and analgesia in inflammatory bowel disease

2016-002210-46Phase 4Completed

Sponsor
Radboudumc
Start
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in Crohn's disease and autoimmune colitis comparing Intravenous lidocaine infusion with Placebo infusion (2 arms). Primary endpoint: Alfentanil requirement during colonoscopy. Started Jul 2016; status: completed.

02

Drugs

lidocaine
03

Conditions

Crohn's diseaseautoimmune colitis

Beyond the preview

Go deeper on 2016-002210-46.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-002210-46.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call